Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Swiss Medica has entered into a collaboration with the National Fibromyalgia Association to market O24 fibromyalgia pain reliever, the first product of its kind developed to specifically address the symptoms of chronic pain associated with the fibromyalgia syndrome.
Subscribe to our email newsletter
O24 fibromyalgia pain reliever will become the first product to carry the National Fibromyalgia Association (NFA) official seal of approval on its packaging. It will be sold over-the-counter, distributed by Medica.
Fibromyalgia is typically characterized by widespread musculoskeletal aches, pain and stiffness, soft tissue tenderness, general fatigue and sleep disturbances. The most common sites of pain include the neck, back, shoulders, pelvic girdle and hands. Fibromyalgia patients experience a range of symptoms, varying in intensity that can fluctuate over time.
The NFA estimates that the average family doctor sees at least one patient each day who is suffering from fibromyalgia and that the syndrome could be costing the US economy as much as $10 billion a year in lost productivity.
Medica will be launching O24 fibromyalgia in pharmacies throughout the US and Canada. Swiss Medica’s O24 essential oil pain neutralizer will be available in over 13,000 stores throughout North America by the end of June 2005.